London, United Kingdom
Syncona is a leading FTSE250 company focused on investing in and building global leaders in life science. Our vision is to deliver transformational treatments to patients in truly innovative areas of healthcare while generating attractive returns for shareholders. We are aligned with two of the premium charitable funders in life science, the Wellcome Trust, original founder of Syncona's life science division, and Cancer Research UK both of which are significant shareholders in Syncona. We are listed on the London Stock Exchange under the ticker SYNC.
26
Total Investments
14
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Biotechnology, Financial Services +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Syncona Investment Management
Recent Investments (26)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Jan 2026 | |
| Series B | •••••• | Oct 2024 | |
| Series B | •••••• | Jul 2024 | |
| Series B | •••••• | Jun 2024 | |
| Series A | •••••• | Jun 2023 | |
•••• ••••
|
Series A | •••••• | Apr 2023 |
|
•••• ••••
|
Series B | •••••• | Apr 2022 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Mar 2022 |
|
•••• ••••
|
Series B | •••••• | Dec 2021 |
|
•••• ••••
|
Series B | •••••• | Nov 2021 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
